A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis von Waldbaum, Arthur S, Schwebke, Jane R, Paull, Jeremy R A, Price, Clare F, Edmondson, Stephanie R, Castellarnau, Alex, McCloud, Philip, Kinghorn, George R

Volltext

Secnidazole Treatment of Bacterial Vaginosis: A Randomized Controlled Trial von Hillier, Sharon L., Nyirjesy, Paul, Waldbaum, Arthur S., Schwebke, Jane R., Morgan, Franklin G., Adetoro, Nikki A., Braun, Carol J.

Volltext

Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis von Chavoustie, Steven E., Carter, Belvia A., Waldbaum, Arthur S., Donders, Gilbert G.G., Peters, Klaus H., Schwebke, Jane R., Paull, Jeremy R.A., Price, Clare F., Castellarnau, Alex, McCloud, Philip, Kinghorn, George R.

Volltext

Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study von Labrie, Fernand, Archer, David F, Bouchard, Céline, Girard, Ginette, Ayotte, Normand, Gallagher, John C, Cusan, Leonello, Baron, Mira, Blouin, François, Waldbaum, Arthur S, Koltun, William, Portman, David J, Côté, Isabelle, Lavoie, Lyne, Beauregard, Adam, Labrie, Claude, Martel, Céline, Balser, John, Moyneur, Érick

Volltext

A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis von Schwebke, Jane R., Carter, Belvia A., Waldbaum, Arthur S., Agnew, Kathy J., Paull, Jeremy R.A., Price, Clare F., Castellarnau, Alex, McCloud, Philip, Kinghorn, George R.

Volltext

Testosterone Patch Increases Sexual Activity and Desire in Surgically Menopausal Women with Hypoactive Sexual Desire Disorder von Simon, James, Braunstein, Glenn, Nachtigall, Lila, Utian, Wulf, Katz, Molly, Miller, Sam, Waldbaum, Arthur, Bouchard, Celine, Derzko, Christine, Buch, Akshay, Rodenberg, Cynthia, Lucas, Johna, Davis, Susan

Volltext

The neurokinin 3 receptor antagonist, fezolinetant, is effective in treatment of menopausal vasomotor symptoms: a randomized, placebo-controlled, double-blind, dose-ranging study von Fraser, Graeme, Lederman, Samuel, Waldbaum, Arthur, Lee, Misun, Skillern, Laurence, Ramael, Steven

Volltext

Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy von Labrie, Fernand, Derogatis, Leonard, Archer, David F., Koltun, William, Vachon, Andrée, Young, Douglas, Frenette, Louise, Portman, David, Montesino, Marlene, Côté, Isabelle, Parent, Julie, Lavoie, Lyne, Beauregard, Adam, Martel, Céline, Vaillancourt, Mario, Balser, John, Moyneur, Érick, Members of the VVA Prasterone Research Group

Volltext

Evaluation of Contraceptive Efficacy and Cycle Control of a Transdermal Contraceptive Patch vs an Oral Contraceptive: A Randomized Controlled Trial von Audet, Marie-Claude, Moreau, Michèle, Koltun, William D, Waldbaum, Arthur S, Shangold, Gary, Fisher, Alan C, Creasy, George W, for the ORTHO EVRA/EVRA 004 Study Group

Volltext

OR33-6 The Neurokinin 3 Receptor Antagonist, Fezolinetant, Is Effective in Treatment of Menopausal Vasomotor Symptoms: A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging... von Fraser, Graeme, Lederman, Samuel, Waldbaum, Arthur, Lee, Misun, Skillern, Laurence, Ramael, Steven

Volltext

Low Dose of Transdermal Estradiol Gel for Treatment of Symptomatic Postmenopausal Women: A Randomized Controlled Trial von Simon, James A, Bouchard, Celine, Waldbaum, Arthur, Utian, Wulf, Zborowski, Joanne, Snabes, Michael C

Volltext

Tranexamic acid increases hemoglobin and ferritin levels in women with heavy menstrual bleeding von Muse, Ken, Mabey, R Garn, Waldbaum, Arthur, Gersten, Janet K, Adomako, Tammie L

Volltext

Long-Term Evaluation of Safety and Health-Related Quality of Life in Women with Heavy Menstrual Bleeding Treated with Oral Tranexamic Acid von Muse, Ken, Lukes, Andrea S, Gersten, Janet, Waldbaum, Arthur, Mabey, R Garn, Trott, Edward

Volltext

Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks von Martel, Céline, Labrie, Fernand, Archer, David F, Ke, Yuyong, Gonthier, Renaud, Simard, Jean-Nicolas, Lavoie, Lyne, Vaillancourt, Mario, Montesino, Marlene, Balser, John, Moyneur, Érick

Volltext

Acceptability of NuvaRing®, a new method of combined contraception von Waldbaum, Arthur S, Funk, Sidney, Alexander, Nancy J

Volltext

Use of porcine xenografts in treatment of Fournier's gangrene von Waldbaum, Robert S., Bordan, Dennis L., Wise, Arthur L.

Volltext